Restoring Nerve Function
Solaxa is a clinical-ready biopharmaceutical company developing treatments for
rare neurodegenerative disease and nerve injury.
We are pursuing both novel and reformulated drugs to
restore nerve function by targeting ion channels.
Our Company: By The Numbers
3
Investigator-initiated IND trials open
13
5 issued and 8 pending US, EU, Canada patents exclusively licensed
138
Cerebellar ataxia patients studied with drug
$8M+
Non-dilutive NIH & DoD grants to co-founders
20+
Peer-reviewed publications by co-founders
7
Different cerebellar ataxias have shown treatment response with drug